re: Official CryptoTalk Thread

So I’ve put about 75% of my crypto funds in BTC, about 12.5% in ETH, and the rest is split between XRP and XLM.

I’ll probably only buy more BTC for the foreseeable future.

Friendly heads up to everyone about Encrypgen and the DNA token. The business and token have been in a sort of hibernation over the past few years. Encrypgen has been making slow but steady progress to build a data set of genomic profiles with promising additions coming soon. The token hasn’t been on an exchange since Cryptopia failed and was hovering around all time lows of $0.01-$0.04 for a while. $DNA will be listed on an up and coming exchange called Coinmetro soon. Some of you that are looking for high risk high reward low cap cryptos should consider. The upside for DNA is massive at these prices.

LINK running over $23. Not a chart reader by any stretch of the imagination but have seen a few people say we should be headed to $28 based on the chart.

What's its purpose?

quote:

---

Way to cherry pick the exact timeframe where link underperformed btc

Zoom out

---

Meh this thread started getting busy again within the past 90 days. I'll stick with my comparison now that we have many more new people reading this that weren't in the market a year ago.

CE, where did you park some LINK that it earning interest? I went back a few pages but couldn’t find your post.

Celsius is an centralized exchange option, or look at bancor if you are interested doing riskier defi stuff.

quote:

---

So wouldn’t you be telling people Link has more room to grow than Bitcoin based on its performance in the last 90 days?

---

No doubt about that - I own some LINK because of that fact. I also think BTC is a more sure thing and if the people are noobs/weak hands, go with the least risk

quote:

---

What's its purpose?

---

I’ve explained more about it several years ago on this board but the general gist is as follows:

Encrypgen is a company founded by Dr. Koepsel, a professor and ethicist (not the best background but bare with me), and his wife who is a genomic scientist. Encrypgen has created what they call the Genechain which is a multichain based blockchain that stores a person’s genomic data and associated metadata anonymously and allows each person to sell access to that data in exchange for the ERC-20 token $DNA. The Genechain currently has 10,000-20,000 genomic profiles and Encrypgen apparently has deals with an insurance conglomerate and a group in Africa to add over 100,000 additional profiles to the network over the next year or two.

So basically its an alternative to 23andMe but with better privacy and it allows individuals to profit from their data with Encrypgen taking a percentage of each transaction like an exchange. The likely buyers of the datasets include smaller pharma groups and university research groups that have a hard time acquiring similar data for a reasonable price from larger companies like 23andMe.

Long term, the exciting possibility is that the DNA token will become used for not only transactions on the genechain but also for buying related services such as ancestry reports.